FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall
fell Friday as the threat of a US government shutdown increased, and as investors awaited the release of key inflation data.) stock soared 6.7% after the delivery giant reported better-than-expected earnings in the fiscal second quarter, while also announcing that it’s planning on spinning off its freight business.) stock plunged 18% after the drugmaker said its experimental next-generation obesity drug CagriSema helped patients cut their weight by 22.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly roseOracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose
Read more »
China Approves Eli Lilly's Donanemab for Early Alzheimer'sChina's food and drug regulator has approved Eli Lilly's Kisunla (donanemab) treatment for early symptomatic Alzheimer's disease, marking the fourth major market to grant approval. This follows approvals in the U.S., Japan, and the UK earlier this year. Donanemab targets beta amyloid, clearing it from the brain and differs from Leqembi in requiring finite dosing once plaques are cleared.
Read more »
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortageThe decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
Read more »
Eli Lilly & Co. Sign Outside Corporate HeadquartersA photo of a sign for Eli Lilly & Co. outside their corporate headquarters in Indianapolis.
Read more »
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, ZepboundEli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
Read more »
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, ZepboundEli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
Read more »